Pharmafile Logo
Pharmafocus logo
Advanced Search

Medical Communications

Showing 15 posts of 6402 posts found.

medications-257333_640

People or profit: What is the best system to regulate drug prices?

March 30, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Conor Kavanagh investigates the role state healthcare institutions play in negotiating drug prices, and what steps can be taken for …
Feature
mesa_biotech_accula

FDA invokes emergency powers to authorise 30-minute, handheld COVID-19 test

March 27, 2020 Medical Communications, Sales and Marketing COVID-19, FDA, Mesa Biotech, US, coronavirus

The FDA invoked Emergency Use Authorization powers to approve a rapid, handheld testing kit for COVID-19 coronavirus cases just days …
News
usa-4925212_640

US now leads world in COVID-19 cases as report warns it could face 80,000 deaths in four months

March 27, 2020 Medical Communications, Research and Development

The US now leads the world in total number of COVID-19 cases with more than 85,500 positives, ahead of China’s …
News
top_10_image_2

Top Ten most popular articles on Pharmafile.com this week

March 27, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, coronavirus

The COVID-19 global pandemic continues to dominate the news cycle. The first clinical trial using danoprevir (Ganovo) in treating COVID-19 …
News
0000000000___30562517863_f4ff8e801a_b

British Prime Minister Boris Johnson tests positive for coronavirus

March 27, 2020 Medical Communications COVID-19, Coroanvirus

British Prime Minister Boris Johnson has tested positive for coronavirus, developing mild symptoms over the last 24 hours which included …
News

Teva donates millions of hydroxychloroquine sulfate tablets, touted by Trump as coronavirus treatment

March 27, 2020 Medical Communications Trump, coronavirus

Teva pharmaceuticals have said they will provide ten million doses of its anti-malaria drug hydroxychloroquine, which President Trump has been …
News
190509-f-jf989-032

COVID-19 may significantly hurt the drug supply chains of the biggest pharmaceutical companies

March 27, 2020 Medical Communications COVID-19, Coroanvirus, Wuhan Coronavirus, china coronavirus

The increasing spread of the COVID-19 coronavirus pandemic threatens the drug supply lines of the biggest pharmaceutical companies, including AstraZeneca, …
News
microsoftteams-image_1

Eyeforpharma Barcelona 2020 is now a free virtual event

March 25, 2020 Medical Communications, Research and Development COVID-19, Eyeforpharma Barcelona 2020, coronavirus, events, eyeforpharma, pharma

In light of the rapidly evolving impact of the COVID-19 virus, eyeforpharma has decided to turn eyeforpharma Barcelona 2020 into …
News
screen_shot_2020-01-29_at_16

Sustainability and security: How packaging is modernising pharma

March 24, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing counterfeit medicines, falsified medicines, feature, packaging, pharma

In a world living in the shadow of substandard and falsified medicines, climate change and antimicrobial resistance, pharmaceutical packaging will …
Feature
shutter

COVID-19: Gilead freezes compassionate access to remdesivir due to “overwhelming demand”, BMS and Lilly delay new study launches

March 24, 2020 Manufacturing and Production, Medical Communications, Research and Development Bristol-Myers Squibb, Eli Lilly, Gilead, Roche, cornavirus, pharma

As national governments continue to ramp up measures to contain the ongoing COVID-19 coronavirus outbreak, so too are pharma and …
News
lung_cancer_on_chest_x-ray

AI may help predict patient response to non-small cell lung cancer therapies

March 23, 2020 Medical Communications, Sales and Marketing Cancer, Lesions, cancer treatment, tumour treatment

Researchers have used artificial intelligence to train algorithms to predict tumour sensitivity to systemic cancer therapies. Radiologists previously determined if …
News
california_state_flag

Los Angeles County and California State near lockdown after “safer-at-home” mandate is announced

March 20, 2020 Medical Communications Wuhan Coronavirus, china coronavirus, coronavirus

Last night, Los Angeles County, and later California State, announced a mandate to make people work and stay at home …
News
gilead-sciences

FDA greenlights Gilead’s Epclusa in hepatitis C patients over six years old

March 20, 2020 Medical Communications, Research and Development Epclusa, Gilead, pharma

Gilead’s Epclusa (sofosbuvir and velpatasvir) has been awarded new marketing approval from the FDA in the treatment of hepatitis C …
News
top_10_image_2

Top Ten most popular articles on Pharmafile.com this week

March 20, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Chinese Coronavirus, Wuhan Coronavirus, china coronavirus, coronavirus

The COVID-19 coronavirus continues to dominate the news: A flu drug has appeared to be effective in treating COVID-19 while …
News
europe-1395916_640

Drug launches across Europe will be affected by coronavirus

March 20, 2020 Medical Communications, Sales and Marketing EU, Europe, coronavirus, pharma

The COVID-19 pandemic will affect European launches of drugs for a host of diseases including HIV, cancer and sickle cell …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025